A two-round Delphi study examining consensus of recommended clinical practices for patients with ventricular assist devices as destination therapy

Progress in Transplantation

Volumn 21, Issue 1, 2011, Pages 15-26

  Chichetti, Joanne ^a  

^a ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS; DELPHI STUDY; HEALTH CARE QUALITY; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; MEDICARE; MORTALITY; MULTICENTER STUDY; PRACTICE GUIDELINE; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICS; SURVIVAL; UNITED STATES;

CONSENSUS; DELPHI TECHNIQUE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MEDICARE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT; SURVIVAL ANALYSIS; UNITED STATES;

EID: 79959621443     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.21.1.v32706724w42k277     Document Type: Article

References (25)

1. Clegg AJ, Scott DA, Loveman E, Colquitt J, Royle P, Bryant J. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage hear failure: a systematic review and economic evaluation. Int J Technol Assess Health Care. 2007;23(2):261-268. (Pubitemid 46642732)
2. Stahovich M, Chillcott S, Dembitsky WP. The next treatment option: using ventricular assist devices for heart failure. Crit Care Nurs Q. 2007;30(4):337-346. (Pubitemid 47415125)
3. Thoratec Corporation. Advance Practice Guidelines for HeartMate Destination Therapy. Vol 1. Pleasanton, CA: Thoratec Corporation; 2004.
4. Centers for Medicare and Medicaid Services. Foreword: Purpose for National Coverage Determinations Manual. http://www.cms.hhs.gov/transmittals/ downloads/R2NCD1.pdf. Accessed June 26, 2008.
5. Bond E, Bolton B, Nelson K. Nursing education and implications for left ventricular assist device destination therapy. Prog Cardiovasc Nurs. 2004;19(3):95-101.
6. Food and Drug Administration. Thoratec HeartMate II LVAS. http://www.fda.gov/MedicalDevices/ProductsandMedical Procedures/ DeviceApprovalsandClearances/RecentlyApproved Devices/ucm201473.htm. Accessed February 28, 2010.
7. Centers for Medicare and Medicaid Services. Decision memo for ventricular assist devices as destination therapy. 2007. https://www.cms.hhs.gov/mcd/ viewdecisionmemo.asp?from2 =viewdecisionmemo.asp&id=187&. Accessed May 25, 2008.
8. Joint Commission. Ventricular assist device destination therapy certification final recommendations. 2007. http://www .jointcommission.org/NR/ rdonlyres/A382721B-25BC-4F06-8EFD-C9C6A1F221BD/0/VAD.pdf. Accessed November 21, 2010.
9. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-1443.
10. Thoratec Corporation. Advance Practice Guidelines for Heart-Mate Destination Therapy. Vol 2. Pleasanton, CA: Thoratec Corporation; 2004.
11. Gronda E, Bourge RC, Costanzo MR, et al. Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates. J Heart Lung Transplant. 2006;25(9): 1043-1056. (Pubitemid 44376580)
12. Chan S, McCowen KC, Blackburn GL. Nutrition management in the ICU. Chest. 1999;115(5 suppl):145S-148S. (Pubitemid 29228273)
13. Dang NC, Topkara VK, Kim BT, Lee BJ, Remoli R, Naka Y. Nutritional status in patients on left ventricular assist device support. J Thorac Cardiovasc Surg. 2005;130(5):e3-e4. (Pubitemid 41543239)
14. Long JW, Healy AH, Rasmusson BY, et al. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg. 2008;135(6):1353-1361. (Pubitemid 351787629)
15. Mustafa I, Leverve X. Metabolic and nutritional disorders in cardiac cachexia. Nutrition. 2001;17(9):756-760. (Pubitemid 32816331)
16. Keeney S, Hasson F, McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs. 2006;53(2):205-212. (Pubitemid 43455545)
17. McKenna HP. The Delphi technique: a worthwhile research approach for nursing? J Adv Nurs. 1994;19(6):1221-1225.
18. Crisp J, Pelletier D, Duffield C, Adams A, Nagy S. The Delphi method? Nurs Res. 1997;46(2):116-118.
19. O'Hara ML, Sample S, Williams MA. Heart failure: from the ICU to step-down-and home. Nurs Manage. 2006;37(8):36-41.
20. Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Publ Health. 1984;74(9):979-983. (Pubitemid 14059576)
21. Wang H, Wang S. Discovering patterns of missing data in survey databases: an application of rough sets. Exp Syst Application. 2009;36(3):6256-6260.
22. Goodman CM. The Delphi technique: a critique. J Adv Nurs. 1987;12(6):729-734.
23. Sumsion T. The Delphi technique: an adaptive research tool. Br J Occupation Ther. 1998;61(4):153-156. (Pubitemid 128452556)
24. Centers for Medicare and Medicaid Services. VAD Destination Therapy centers. 2007. http://www.cms.gov/MedicareApproved Facilitie/VAD/list.asp? filterType=none&filterByDID=0 &sortByDID=1&sortOrder= descending&intNumPerPage=10. Accessed September 11, 2010.
25. Food and Drug Administration Web site. FDA approves left ventricular assist system for severe heart failure patients: device provides support for those who are not acceptable transplant candidates. 2010. http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm198172.htm. Accessed September 11, 2010.